361 related articles for article (PubMed ID: 25604328)
1. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
[TBL] [Abstract][Full Text] [Related]
2. Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients.
Silva-Freitas ML; Cota GF; Machado-de-Assis TS; Giacoia-Gripp C; Rabello A; Da-Cruz AM; Santos-Oliveira JR
PLoS One; 2016; 11(12):e0167512. PubMed ID: 27907136
[TBL] [Abstract][Full Text] [Related]
3. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
[TBL] [Abstract][Full Text] [Related]
5. Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection.
Santos-Oliveira JR; Regis EG; Giacoia-Gripp CB; Valverde JG; Alexandrino-de-Oliveira P; Lindoso JÂ; Goto H; Oliveira-Neto MP; Guerra JO; Grinsztejn B; Jerônimo SB; Morgado MG; Da-Cruz AM
J Infect Dis; 2013 Jul; 208(1):57-66. PubMed ID: 23539743
[TBL] [Abstract][Full Text] [Related]
6. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
[TBL] [Abstract][Full Text] [Related]
7. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
[TBL] [Abstract][Full Text] [Related]
8. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
9. Impaired Thymic Output Can Be Related to the Low Immune Reconstitution and T Cell Repertoire Disturbances in Relapsing Visceral Leishmaniasis Associated HIV/AIDS Patients.
Silva-Freitas ML; Corrêa-Castro G; Cota GF; Giacoia-Gripp C; Rabello A; Teixeira Dutra J; de Vasconcelos ZFM; Savino W; Da-Cruz AM; Santos-Oliveira JR
Front Immunol; 2020; 11():953. PubMed ID: 32508833
[No Abstract] [Full Text] [Related]
10. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
[TBL] [Abstract][Full Text] [Related]
11. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
[TBL] [Abstract][Full Text] [Related]
12. High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.
Vallejo A; Abad-Fernández M; Moreno S; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):267-75. PubMed ID: 25142804
[TBL] [Abstract][Full Text] [Related]
13. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
14. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
[TBL] [Abstract][Full Text] [Related]
15. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.
Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM
Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071
[TBL] [Abstract][Full Text] [Related]
16. High levels of anti-Leishmania IgG3 and low CD4
Kuschnir RC; Pereira LS; Dutra MRT; de Paula L; Silva-Freitas ML; Corrêa-Castro G; da Costa Cruz Silva S; Cota G; Santos-Oliveira JR; Da-Cruz AM
BMC Infect Dis; 2021 Apr; 21(1):369. PubMed ID: 33874901
[TBL] [Abstract][Full Text] [Related]
17. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
Kvale D; Ormaasen V; Kran AM; Johansson CC; Aukrust P; Aandahl EM; Frøland SS; Taskén K
AIDS; 2006 Apr; 20(6):813-20. PubMed ID: 16549964
[TBL] [Abstract][Full Text] [Related]
18. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Mira JA; Corzo JE; Rivero A; Macias J; De Leon FL; Torre-Cisneros J; Gomez-Mateos J; Jurado R; Pineda JA
Am J Trop Med Hyg; 2004 Mar; 70(3):298-301. PubMed ID: 15031520
[TBL] [Abstract][Full Text] [Related]
19. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
20. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]